| (11) | Number of the document | 4858 |
| (21) | Number of the application | a 2021 0066 |
| (22) | Filing date of the application | 2021.09.30 |
| | Date of filing the request for examination | (de fond) 12.01.2022 |
| (71) | Name(s) of applicant(s), code of the country | IP UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE "NICOLAE TESTEMITANU" DIN REPUBLICA MOLDOVA, MD; |
| (72) | Name(s) of inventor(s), code of the country | GUDUMAC Valentin, MD; PANTEA Valeriana, MD; CEBAN Emil, MD; ANDRONACHE Lilia, MD; TAPCOV Victor, MD; GULEA Aurelian, MD; GHINDA Sergiu, MD; |
| (73) | Name(s) of owner(s), code of the country | IP UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE "NICOLAE TESTEMITANU" DIN REPUBLICA MOLDOVA, MD; |
| (54) | Title of the invention | Use of chloro-{N-ethyl-N'-[phenyl(pyridin-2-yl)methylidene]carbamohydrazonethioato}copper as a growth factor inhibitor
|
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | A61K 31/30 (2006.01); A61K 31/175 (2006.01); A61K 31/4402 (2006.01); A61P 35/00 (2006.01); A61P 39/06 (2006.01); C07F 1/08 (2006.01); C07C 337/08 (2006.01); C07D 213/50 (2006.01); |
| (19) | Country | MD |
| (41) | Date of publication of the application | 2023.03.31 |
| (45) | Date of publication of patent granting decision: | 2023.05.31 |
| (47) | Date of issuance of patent | 2023.12.31 |
| | Substantive examiner(s) | LEVIŢCHI Svetlana |
| | Payment for maintenance up to the date | 2026.09.30 |